Please enable JavaScript to continue using this application.

Compare $ARMP vs $VTVT | Chartloom

Compare

$ARMP vs $VTVT

Armata Pharmaceuticals Inc · vTv Therapeutics Inc

ARMP

Armata Pharmaceuticals Inc

VTVT

vTv Therapeutics Inc

Compare $ARMP vs $VTVT

Comparing Armata Pharmaceuticals Inc and vTv Therapeutics Inc

ARMPArmata Pharmaceuticals Inc

VTVTvTv Therapeutics Inc

ARMPArmata Pharmaceuticals Inc

Market cap

$133M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.3%

YTD performance

-44.7%

52W performance

12.7%

FCF yield

-19.4%

VTVTvTv Therapeutics Inc

Market cap

$123M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

216600.0%

YTD performance

-21.3%

52W performance

38.3%

FCF yield

-13.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARMP

VTVT

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

VTVT

vTv Therapeutics Inc

Market Cap

ARMP$133M

VTVT$123M

Enterprise Value

ARMP$393M

VTVT$36M

Price

ARMP$3.63

VTVT$31.18

P/E Ratio

ARMPN/A

VTVTN/A

P/S Ratio

ARMP24.04x

VTVT3.33x

EV/Sales

ARMP70.87x

VTVT0.98x

EV/EBITDA

ARMP0.00x

VTVT0.00x

P/B Ratio

ARMP6.85x

VTVT1.53x

P/FCF Ratio

ARMPN/A

VTVTN/A

EV/FCF

ARMP-15.23x

VTVT-2.16x

PEG Ratio

ARMPN/A

VTVTN/A

Forward P/E (NTM)

ARMPN/A

VTVTN/A

Forward P/S (NTM)

ARMPN/A

VTVTN/A

Revenue (TTM)

ARMP$6M

VTVT$37M

Revenue Growth (YoY)

ARMP-19.3%

VTVT216600.0%

Forward Rev Growth

ARMP-35.3%

VTVT-97.3%

Gross Margin (TTM)

ARMP0.0%

VTVT0.0%

Operating Margin (TTM)

ARMP0.0%

VTVT63.1%

EBITDA Margin (TTM)

ARMP-603.4%

VTVT-25.1%

Net Margin (TTM)

ARMP-3467.0%

VTVT-12.9%

FCF Margin (TTM)

ARMP-465.3%

VTVT-45.5%

Net Income (TTM)

ARMP$-192M

VTVT$-5M

FCF (TTM)

ARMP$-26M

VTVT$-17M

EPS (TTM)

ARMP-$3.10

VTVT-$0.38

ROE (TTM)

ARMP-12000.0%

VTVT-627.0%

ROA (TTM)

ARMP-23569.0%

VTVT-506.0%

ROIC (TTM)

ARMP-8123.0%

VTVT-626.0%

Cash

ARMP$24M

VTVT$87M

Debt

ARMP$284M

VTVT$0

Net Cash/Debt

ARMP$-260M

VTVT$87M

Current Ratio (TTM)

ARMP0.11x

VTVT12.48x

Quick Ratio (TTM)

ARMP0.11x

VTVT12.42x

Debt/Equity (TTM)

ARMP1.38x

VTVT0.00x

Debt/Assets (TTM)

ARMP0.0%

VTVT0.0%

Interest Coverage (TTM)

ARMPN/A

VTVTN/A

Net Debt/EBITDA (TTM)

ARMP0.00x

VTVT0.00x

Beta

ARMP1.66

VTVT0.23

52W Performance

ARMP12.7%

VTVT38.3%

YTD Performance

ARMP-44.7%

VTVT-21.3%

% from 52W High

ARMP-77.8%

VTVT-29.1%

% from 52W Low

ARMP17.5%

VTVT59.9%

Asset Turnover (TTM)

ARMP0.07x

VTVT0.37x

FCF Yield (TTM)

ARMP-19.4%

VTVT-13.6%

Earnings Yield (TTM)

ARMP-144.2%

VTVT-3.9%

Dividend Yield (TTM)

ARMPN/A

VTVTN/A

Rule of 40

ARMP-484.6

VTVT216,554.5

EV/GP/RG

ARMPN/A

VTVTN/A

Ticker research

View ARMP research View VTVT research

Metric	ARMP Armata Pharmaceuticals Inc	VTVT vTv Therapeutics Inc
Market & Valuation
Market Cap	$133M	$123M
Enterprise Value	$393M	$36M
Price	$3.63	$31.18
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	3.33x
EV/Sales	70.87x	0.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	1.53x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	-2.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$37M
Revenue Growth (YoY)	-19.3%	216600.0%
Forward Rev Growth	-35.3%	-97.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	63.1%
EBITDA Margin (TTM)	-603.4%	-25.1%
Net Margin (TTM)	-3467.0%	-12.9%
FCF Margin (TTM)	-465.3%	-45.5%
Net Income (TTM)	$-192M	$-5M
FCF (TTM)	$-26M	$-17M
EPS (TTM)	-$3.10	-$0.38
ROE (TTM)	-12000.0%	-627.0%
ROA (TTM)	-23569.0%	-506.0%
ROIC (TTM)	-8123.0%	-626.0%
Financial Health
Cash	$24M	$87M
Debt	$284M	$0
Net Cash/Debt	$-260M	$87M
Current Ratio (TTM)	0.11x	12.48x
Quick Ratio (TTM)	0.11x	12.42x
Debt/Equity (TTM)	1.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	0.23
52W Performance	12.7%	38.3%
YTD Performance	-44.7%	-21.3%
% from 52W High	-77.8%	-29.1%
% from 52W Low	17.5%	59.9%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.37x
FCF Yield (TTM)	-19.4%	-13.6%
Earnings Yield (TTM)	-144.2%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	216,554.5
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View VTVT research

Valuation

P/S Ratio

VTVT

3.33x

ARMP

24.04x

EV/FCF

ARMP

-15.23x

VTVT

-2.16x

Growth & revenue

Revenue Growth TTM

VTVT

216600.0%

ARMP

-19.3%

Forward Revenue Growth

ARMP

-35.3%

VTVT

-97.3%

Profitability & performance

Gross Margin

ARMP

0.0%

VTVT

0.0%

ROE

VTVT

-627.0%

ARMP

-12000.0%

FCF Yield %

VTVT

-13.6%

ARMP

-19.4%

52-Week Performance

VTVT

38.3%

ARMP

12.7%

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

VTVT

vTv Therapeutics Inc

Market Cap

ARMP$133M

VTVT$123M

Enterprise Value

ARMP$393M

VTVT$36M

Price

ARMP$3.63

VTVT$31.18

P/E Ratio

ARMPN/A

VTVTN/A

P/S Ratio

ARMP24.04x

VTVT3.33x

EV/Sales

ARMP70.87x

VTVT0.98x

EV/EBITDA

ARMP0.00x

VTVT0.00x

P/B Ratio

ARMP6.85x

VTVT1.53x

P/FCF Ratio

ARMPN/A

VTVTN/A

EV/FCF

ARMP-15.23x

VTVT-2.16x

PEG Ratio

ARMPN/A

VTVTN/A

Forward P/E (NTM)

ARMPN/A

VTVTN/A

Forward P/S (NTM)

ARMPN/A

VTVTN/A

Revenue (TTM)

ARMP$6M

VTVT$37M

Revenue Growth (YoY)

ARMP-19.3%

VTVT216600.0%

Forward Rev Growth

ARMP-35.3%

VTVT-97.3%

Gross Margin (TTM)

ARMP0.0%

VTVT0.0%

Operating Margin (TTM)

ARMP0.0%

VTVT63.1%

EBITDA Margin (TTM)

ARMP-603.4%

VTVT-25.1%

Net Margin (TTM)

ARMP-3467.0%

VTVT-12.9%

FCF Margin (TTM)

ARMP-465.3%

VTVT-45.5%

Net Income (TTM)

ARMP$-192M

VTVT$-5M

FCF (TTM)

ARMP$-26M

VTVT$-17M

EPS (TTM)

ARMP-$3.10

VTVT-$0.38

ROE (TTM)

ARMP-12000.0%

VTVT-627.0%

ROA (TTM)

ARMP-23569.0%

VTVT-506.0%

ROIC (TTM)

ARMP-8123.0%

VTVT-626.0%

Cash

ARMP$24M

VTVT$87M

Debt

ARMP$284M

VTVT$0

Net Cash/Debt

ARMP$-260M

VTVT$87M

Current Ratio (TTM)

ARMP0.11x

VTVT12.48x

Quick Ratio (TTM)

ARMP0.11x

VTVT12.42x

Debt/Equity (TTM)

ARMP1.38x

VTVT0.00x

Debt/Assets (TTM)

ARMP0.0%

VTVT0.0%

Interest Coverage (TTM)

ARMPN/A

VTVTN/A

Net Debt/EBITDA (TTM)

ARMP0.00x

VTVT0.00x

Beta

ARMP1.66

VTVT0.23

52W Performance

ARMP12.7%

VTVT38.3%

YTD Performance

ARMP-44.7%

VTVT-21.3%

% from 52W High

ARMP-77.8%

VTVT-29.1%

% from 52W Low

ARMP17.5%

VTVT59.9%

Asset Turnover (TTM)

ARMP0.07x

VTVT0.37x

FCF Yield (TTM)

ARMP-19.4%

VTVT-13.6%

Earnings Yield (TTM)

ARMP-144.2%

VTVT-3.9%

Dividend Yield (TTM)

ARMPN/A

VTVTN/A

Rule of 40

ARMP-484.6

VTVT216,554.5

EV/GP/RG

ARMPN/A

VTVTN/A

Ticker research

View ARMP research View VTVT research

Metric	ARMP Armata Pharmaceuticals Inc	VTVT vTv Therapeutics Inc
Market & Valuation
Market Cap	$133M	$123M
Enterprise Value	$393M	$36M
Price	$3.63	$31.18
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	3.33x
EV/Sales	70.87x	0.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	1.53x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	-2.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$37M
Revenue Growth (YoY)	-19.3%	216600.0%
Forward Rev Growth	-35.3%	-97.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	63.1%
EBITDA Margin (TTM)	-603.4%	-25.1%
Net Margin (TTM)	-3467.0%	-12.9%
FCF Margin (TTM)	-465.3%	-45.5%
Net Income (TTM)	$-192M	$-5M
FCF (TTM)	$-26M	$-17M
EPS (TTM)	-$3.10	-$0.38
ROE (TTM)	-12000.0%	-627.0%
ROA (TTM)	-23569.0%	-506.0%
ROIC (TTM)	-8123.0%	-626.0%
Financial Health
Cash	$24M	$87M
Debt	$284M	$0
Net Cash/Debt	$-260M	$87M
Current Ratio (TTM)	0.11x	12.48x
Quick Ratio (TTM)	0.11x	12.42x
Debt/Equity (TTM)	1.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	0.23
52W Performance	12.7%	38.3%
YTD Performance	-44.7%	-21.3%
% from 52W High	-77.8%	-29.1%
% from 52W Low	17.5%	59.9%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.37x
FCF Yield (TTM)	-19.4%	-13.6%
Earnings Yield (TTM)	-144.2%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	216,554.5
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View VTVT research